Laparoscopic surgery undoubtedly has a role in the management of gynec
ologic cancer. As a matter of fact, the current strategy in all fields
of oncology is to select high-risk and low-risk patients. The reasoni
ng behind such a strategy is essentially to avoid for the latter the h
azards of heavy treatment and to lessen the cost-to-benefit ratio. Wit
h this in mind, the laparoscopic pelvic lymphadenectomy, which is the
emblematic procedure in the field of oncologic laparoscopic surgery, a
ppears to be very useful, but only in cases where an actual risk of ly
mph node involvement does exist and where it may be followed in patien
ts with negative nodes by a less aggressive treatment. Gynecologic onc
ologists are the only ones who can at the same time make a diagnosis,
decide which treatment may be done in the patients with negative nodes
, and perform the needed operation. The disasters seen in relation to
ovarian cysts demonstrate the danger that does exist if we allow oncol
ogic laparoscopic surgery to fall into inexperienced hands.